Pfizer Fights Celebrex Plaintiffs' Bid To Bar Experts

Law360, New York (August 14, 2007, 12:00 AM EDT) -- Firing the latest salvo in a dispute over proposed testimony, Pfizer Inc. has opposed a bid by plaintiffs in the multidistrict product liability litigation over its anti-inflammatory drug Celebrex to bar certain experts' opinions.

The drug company said in court documents filed Monday in the U.S. District Court for the Northern District of California that the court should deny the plaintiffs' July 20 motion to bar the testimony of four doctors Pfizer has designated as expert witnesses in the case, arguing that the plaintiffs have focused...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.